BioCentury
ARTICLE | Company News

Warner Chilcott, Actavis Inc. deal

October 7, 2013 7:00 AM UTC

Generics company Actavis completed its acquisition of specialty pharma Warner Chilcott in a stock deal that values Warner Chilcott at about $5 billion. Actavis and Warner combined to form Actavis plc...